Stories

More about

Astellas’ VALUE powered by people — New Challenge of HR

Patient centricity at Astellas—all about action

Corporate Strategic Plan 2021—dedicated to realization

#Corporate Strategic Plan

#Fundamental Cures

#Cell Therapy

#Genetic Regulation / Gene Therapy

#Focus Area Approach

#Immuno-Oncology

#Blindness & Regeneration

Cell therapy—unlocking groundbreaking potential

#Cell Therapy

#Universal Cells

#Universal Donor Cell

#Immune Response

#Blindness & Regeneration

#Focus Area Approach

#Primary Focus

#Genetic Regulation / Gene Therapy

Building a foundation to create innovative treatments under the Corporate Strategic Plan 2018

#Corporate Strategic Plan

#Focus Area Approach

#Primary Focus

#Cell Therapy

#Blindness & Regeneration

#Mitochondria

#Genetic Regulation / Gene Therapy

#Immuno-Oncology

#Rx+

Creating innovative medicines through collaboration between AI and humans

#AI

#Machine Learning

#Robotics

#Human Genetics

#Data Science

#Big Data

#Real-World Data

#Digital Transformation

Accelerating the discovery and development of novel drugs that target mitochondrial functions.

#Focus Area Approach

#Primary Focus

#Mitobridge

#Mitochondria

#PPAR

#Cell Therapy

#Astellas Institute for Regenerative Medicine

#Universal Cells

To free patients from the fear of vision loss and offer hope for recovery of lost sight.

#Focus Area Approach

#Primary Focus

#Blindness & Regeneration

#Cell Therapy

#Genetic Regulation / Gene Therapy

#Adeno-Associated Viral

#Astellas Institute for Regenerative Medicine

#Universal Cells

#Immune Response

Astellas’ Flying Star Fund by Astellas and its volunteer employees.